Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and is caused by an expansion of cytosine-guanine-guanine (CGG) repeats in the FMR1 gene. 
Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and is caused by an expansion of cytosine-guanine-guanine (CGG) repeats in the FMR1 gene. Female premutation allele carriers are at risk to have an affected child. Currently, specific population-based carrier screening for FXS is not recommended. Previous studies exploring female premutation carrier frequency have been limited by size or ethnicity. This retrospective study provides a pan-ethnic estimate of the Fragile X premutation carrier frequency in a large, ethnically diverse population of women referred for routine carrier screening during a specified time period at Progenity, Inc. Patient ethnicity was self-reported and categorized as: African American, Ashkenazi Jewish, Asian, Caucasian, Hispanic, Native American, Other/Mixed/Unknown, or Sephardic Jewish. FXS test results were stratified by ethnicity and repeat allele category. Total premutation carrier frequency was calculated and compared against each ethnic group. A total of 134,933 samples were included. The pan-ethnic premutation carrier frequency was 1 in 201. Only the Asian group differed significantly from this frequency. Using the carrier frequency of 1 in 201, a conservative pan-ethnic risk estimate for a male fetus to have FXS can be calculated as 1 in 2,412. This risk is similar to the highest ethnic-based fetal risks for cystic fibrosis and spinal muscular atrophy, for which population-wide screening is currently recommended. This study adds to the literature and supports further evaluation into specific population-wide screening recommendations for FXS.
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| I N TR ODU C TI ON
Expansion of CGG repeats in the FMR1 gene cause fragile X syndrome (FXS), the most common inherited cause of intellectual disability and autism (Saul & Tarleton, 1998) . Women who carry a repeat allele in the premutation range are at risk to have an affected child through expansion during meiosis. Current guidelines for FXS carrier testing in women include: a history of ovarian insufficiency; a family history of FXS/related disorders, unexplained neuropsychiatric symptoms, or premature ovarian insufficiency; and any woman who requests testing, regardless of her family history (American College of Obstetricians and Gynecologists Committee on Genetics [ACOG], 2017a [ACOG], , 2017b Finucane et al., 2012; Sherman, Pletcher, & Driscoll, 2005) .
Some of the concerns of implementing specific population-based carrier screening for FXS include limited data on the frequency of premutation carriers; the variability of the condition, particularly in girls; and the risk for carriers to have symptoms related to having a premutation allele .
Diagnosis of FXS in affected individuals is often delayed due to the variability in symptoms in early childhood. Approximately 25% of families have a second child with FXS prior to receiving the diagnosis for their first child (Bailey, Raspa, Bishop, & Holiday, 2009; Bailey, Skinner, & Sparkman, 2003) , and this information is not always shared with extended family members (Raspa, Edwards, Wheeler, Bishop, & Bailey, 2016) . These factors increase the risk of missing female premutation carriers based on current screening guidelines. Therefore, professionals have advocated for exploring feasibility and appropriateness of expanded carrier testing for FXS Finucane et al., 2012; Hill, Archibald, Cohen, & Metcalfe, 2010; Sherman et al., 2005) .
Estimates of the prevalence of FXS have changed over time, with more recent suggestions of approximately 1 in 4,000 individuals (Bailey et al., 2017) . Previous studies have also attempted to define population frequency of female premutation allele carriers. Comparisons between studies have been difficult due to differences in the definition of premutation CGG repeat size, selection bias, and small or ethnically homogenous populations (Hill et al., 2010) . Recent published estimates of female premutation carrier frequency in the United States range from 1 in 148 to 1 in 178 (Hantash et al., 2011; Maenner et al., 2013; Seltzer et al., 2012) . Differences in premutation carrier frequency have been noted across ethnicities (Genereux & Laird, 2013; Weiss et al., 2014) . This study furthers the literature by providing a pan-ethnic estimate of the female premutation carrier frequency in a large, ethnically diverse population of women referred for routine carrier screening.
| M A TE RI A L S A ND M E TH ODS
This retrospective cohort study utilized data from all female patients referred to Progenity, Inc., a commercial molecular diagnostics laboratory, for carrier screening that included FXS testing as part of their routine clinical management during a specified time period. alleles (Saul & Tarleton, 1998 Test results were stratified by ethnicity and repeat allele category.
Descriptive statistics were used to generate demographic data. Overall frequencies were generated for each repeat size group. Total female premutation allele frequency was calculated. The overall premutation allele frequency in this study was compared to those from the Seltzer et al. (2012) and Hantash et al. (2011) studies using the assumption that the cohorts followed a Poisson process and computing a p-value according to the method in Agresti (2002) . This method could not be used to compare the frequency from this study to that of Maenner et al. (2013) due to the latter study's population structure, in which many of the individuals tested were related to one another.
Premutation allele carrier frequencies were generated for each ethnicity by modelling the frequencies as a Poisson process. Confidence intervals for carrier frequencies were estimated using the chisquared distribution (Garwood, 1936) . Upper and lower bounds of the 95% confidence intervals were approximated as a rational number whose numerator is 1 (e.g., 1/k for some integer value of k). The value of k was determined to be that which minimized the difference between 1/k and the target frequency.
Multiple analyses were then used to test if the carrier frequencies varied by ethnicity. These included the chi-square test for independence (McHugh, 2013), Cramer's V statistic for association, and the Etest (Krishnamoorthy & Thomson, 2004) . Power analysis was performed for the chi-square test of independence using the GPower program (Faul, Erdfelder, Lang, & Buchner, 2007) . Power was set to 0.95, a was set to 0.05, effect size w was set to 0.05, and degrees of freedom was set to 6, which provided a necessary sample size of 8,343.
The E-test was used to evaluate, for each pair of ethnicity categories, ).
| D ISC USSION
This study identified an overall fragile X premutation allele frequency of Both the Maenner et al. (2013) and Seltzer et al. (2012) studies utilized random population samples that had no indication for carrier screening.
For this study, the specific reason for each individual undergoing screening could not be obtained; therefore, it is possible that some of the individuals could be at a higher than average risk to be premutation carriers based on personal or family history. Interestingly, a 2012 study by Tas This study identified statistically significant differences in fragile X premutation allele frequency among some of the ethnic groups. However, when comparing individual groups to the overall pan-ethnic frequency, the only group remaining significantly different was the Asian group. The lower frequency in the Asian group supports previous findings in this population (Genereux & Laird, 2013; Hill et al., 2010) . frequencies differ somewhat between the two studies, the overall premutation frequency is similar, suggesting that the differences seen between the individual ethnic groups could be related to the smaller sample sizes of these groups as compared to the entire population.
Estimates of the frequency of the fragile X premutation allele in the general population have increased over time, suggesting that carriers for the premutation allele are more common than previously described (Hill et al., 2010) . Although professional societies have recently supported expanded carrier screening as an appropriate option for all ethnicities, population-wide recommendations for carrier testing are currently limited to cystic fibrosis (CF) and spinal muscular atrophy (SMA) (ACOG, 2017a (ACOG, , 2017b Edwards et al., 2015) . Carrier frequencies for these conditions vary among different ethnicities (between 1 in 24 in Ashkenazi Jewish individuals and 1 in 94 for Asians for CF, and between 1 in 35 for Caucasians and 1 in 117 for Hispanics for SMA) (ACOG, 2017a (ACOG, , 2017b . These carrier frequencies are higher than the pan-ethnic female fragile X premutation carrier frequency identified in this study (1 in 201). However, the overall fetal risk for FXS may be similar, given that the inheritance pattern of FXS only requires the mother to be a premutation allele carrier, whereas autosomal recessive diseases require both partners to be carriers of a condition.
As an example, the ethnicity-based risk for an Ashkenazi Jewish couple to have a child with CF is 1 in 2,304: 1/24 3 1/24 3 1/4 (probability of inheriting a mutation from both parents). The pan-ethnic risk for a couple to have a male child with FXS may be similar to this. Using the carrier frequency data from our study, a conservative estimate of male fetal risk for FXS can be calculated as: 1/201 3 1 =2 (probability of having a male child) 3 1 =2 (probability of inheriting the premutation allele) 3 1/3 (risk of expansion to a full mutation-see Figure 1 ), which would result in a fetal risk of 1 in 2,412. Of note, Coffee et al. (2009) Current guidelines do not recommend specific population-based screening for FXS based partly on an unclear carrier frequency, variability of FXS, and the risk for carriers to have symptoms related to having a premutation allele. This study provides a pan-ethnic risk estimate of premutation carrier frequency based on a large, diverse population, and suggests that the fetal risk for FXS is comparable to that of CF and SMA. This supports the need for further evaluation into whether population-based screening is appropriate for FXS, including studies that address the psychosocial impact of having a premutation allele.
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Mean # of CGG repeats among female newborns with premutation alleles 
1-66%
Range of risk for a premutation allele of 70 CGG repeats to expand to a full mutation in a child [Nolin et al., 2011; Yrigollen et al. 2012] (66-1)/2
Midpoint of the range of risk for expansion to a full mutation with 70 CGG repeats
32.5% ≈ 1/3
Conservative estimate of risk of a premutation allele expanding to a full mutation in a child   FIG URE 1 Determining an estimated risk of expansion of a premutation allele to a full mutation. Information was gathered from previous publications to determine a conservative estimate of the risk of a premutation allele expanding to a full mutation in a child [Color figure can be viewed at wileyonlinelibrary.com]
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